Live Quote · NASDAQDYNHealthcare· Biotechnology

Dyne Therapeutics, Inc.

$25.98 2.99%($-0.80)
MKT CAP $4.85BNEXT EARNINGS Nov 4, 2026
50%
Bullish
TickerSpark Score
57/100
Mixed
60
Valuation
20
Profitability
20
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DYN research report →

Analyst Price Target
$38.00+46.3% vs. today

Range $24 – $50

Analyst RatingBuy
12 Buy2 Hold0 Sell

Price Chart

+117.04% · this period
$26.78$19.38$11.97Aug 20Feb 20Aug 20
52-Week Range92% of range
Low
$11.64
Current
$25.98
High
$27.30